These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 17268395)
1. Update on duloxetine for the management of stress urinary incontinence. Basu M; Duckett JR Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy in Stress Urinary Incontinence; A Literature Review. Tabei SS; Baas W; Mahdy A Curr Urol Rep; 2024 Jul; 25(7):141-148. PubMed ID: 38727982 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service. Cardozo L; Thorpe A; Warner J; Sidhu M BJU Int; 2010 Aug; 106(4):506-14. PubMed ID: 20132203 [TBL] [Abstract][Full Text] [Related]
4. New developments in the treatment of urinary incontinence. Vella M; Robinson D; Cardozo L; Cartwright R Minerva Urol Nefrol; 2006 Dec; 58(4):299-310. PubMed ID: 17268395 [TBL] [Abstract][Full Text] [Related]
5. Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine. Kershen RT; Hsieh M Curr Urol Rep; 2004 Oct; 5(5):359-67. PubMed ID: 15461912 [TBL] [Abstract][Full Text] [Related]
7. The use of pharmacotherapy for male patients with urgency and stress incontinence. Andersson KE Curr Opin Urol; 2014 Nov; 24(6):571-7. PubMed ID: 25144147 [TBL] [Abstract][Full Text] [Related]
8. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945 [TBL] [Abstract][Full Text] [Related]